Cancer statistics, 2023

Статистика рака, 2023 год
Rebecca L. Siegel, Ahmedin Jemal, Kimberly D. Miller, Nikita Sandeep Wagle
2023-01-01

Cancer incidenceCancer mortalityCancer mortality trendsHuman papillomavirus vaccinationPopulation-based cancer surveillance
Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths in the United States and compiles the most recent data on population-based cancer occurrence and outcomes using incidence data collected by central cancer registries and mortality data collected by the National Center for Health Statistics. In 2023, 1,958,310 new cancer cases and 609,820 cancer deaths are projected to occur in the United States. Cancer incidence increased for prostate cancer by 3% annually from 2014 through 2019 after two decades of decline, translating to an additional 99,000 new cases; otherwise, however, incidence trends were more favorable in men compared to women. For example, lung cancer in women decreased at one half the pace of men (1.1% vs. 2.6% annually) from 2015 through 2019, and breast and uterine corpus cancers continued to increase, as did liver cancer and melanoma, both of which stabilized in men aged 50 years and older and declined in younger men. However, a 65% drop in cervical cancer incidence during 2012 through 2019 among women in their early 20s, the first cohort to receive the human papillomavirus vaccine, foreshadows steep reductions in the burden of human papillomavirus-associated cancers, the majority of which occur in women. Despite the pandemic, and in contrast with other leading causes of death, the cancer death rate continued to decline from 2019 to 2020 (by 1.5%), contributing to a 33% overall reduction since 1991 and an estimated 3.8 million deaths averted. This progress increasingly reflects advances in treatment, which are particularly evident in the rapid declines in mortality (approximately 2% annually during 2016 through 2020) for leukemia, melanoma, and kidney cancer, despite stable/increasing incidence, and accelerated declines for lung cancer. In summary, although cancer mortality rates continue to decline, future progress may be attenuated by rising incidence for breast, prostate, and uterine corpus cancers, which also happen to have the largest racial disparities in mortality.
1
An estimated 1,958,310 new cancer cases and 609,820 cancer deaths will occur in the United States in 2023.
2
Cancer incidence trends were generally more favorable in men; lung cancer declined annually by 2.6% in men versus 1.1% in women from 2015 through 2019.
3
Cervical cancer incidence fell 65% among women in their early 20s from 2012 through 2019, the first cohort to receive human papillomavirus vaccination.
4
Prostate cancer incidence rose 3% annually from 2014 through 2019 after two decades of decline, adding approximately 99,000 cases.
5
The cancer death rate declined 1.5% from 2019 to 2020 and 33% since 1991, corresponding to an estimated 3.8 million deaths averted; rising breast, prostate, and uterine corpus cancer incidence may slow future progress.

Cancer incidence and mortality in the United States (population-based cancer occurrence and outcomes, 2023 estimates)

Temporal and sex-specific trends in cancer incidence and mortality, including disparities among cancer types and the effects of prevention and treatment advances

Publication Details
Publication Date
2023-01-01
Journal
Publisher
ISSN
Cited by
16971
Access Type
Author Information
Authors
Rebecca L. Siegel
Ahmedin Jemal
Kimberly D. Miller
Nikita Sandeep Wagle
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat
Make a presentation
100%